Overview
NeuroPsyAi is a company in the neuropsychiatry sector, headquartered in Braga. The company provides clinicians, including neurologists, psychiatrists, and neuroradiologists, with patient-personalized reports that assist in the early and accurate diagnosis of various neuropsychiatric disorders. NeuroPsyAi processes medical signals and images, such as electroencephalography (EEG), magnetic resonance imaging (MRI), and positron-emission tomography (PET), using proprietary software. This software employs artificial intelligence algorithms to statistically compare patient data with large databases of both patient and healthy subject data, determining the risk probability of conditions like Alzheimer's Disease, Parkinson's Disease, Schizophrenia, and Autism. The analysis pipeline is automated, producing reports within hours of receiving patient data, allowing for the detection of subtle changes in brain structure and function at disease onset.
Details
- Category
- Hospitals and Health Care
- Headquarters
- Braga
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Health data & analytics (clinical decision support), Digital Health, Medical devices, Medical Imaging, Artificial Intelligence, Machine-Learning, Neuroimaging, Neurology, Psychiatry, Neuropsychiatry, Alzheimer's Disease, Parkinson's Disease, and Mental health
- Locations
- Praça Conde Agrolongo, No 123, Edifício GNRATION Braga, 4700-034 Braga, PT
Funding
Total rounds: 1
Last round: Grant, Apr 8, 2018
Last round amount: US$ 6.2K